Silence Therapeutics Plc Overview

Silence Therapeutics Plc Profit Margin

Profitability ratio analysis for SLN.

Quarterly Profit Margin

-3544.31%

↑ 82.36% YoY

As of Mar 2026

Annual Profit Margin (TTM)

-6445.89%

↓ 2867.60% YoY

Trailing 12 months ending Mar 2026

Average Profit Margin (Comparison Companies)

Profit Margin History

Profit Margin Comparison

Annual Profit Margin Growth Rate (%)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin